Lates News

Passage Bio (PASG.US) reported revenue of 0 US dollars in Q3 2025, compared to 0 US dollars in the previous period; earnings per share were -2.44 US dollars, compared to -6.15 US dollars in the previous period, with an expected value of -2.84 US dollars.